ArticleCureus2025
Extracorporeal Membrane Oxygenation in Massive Pulmonary Hemorrhage Secondary to Arteriovenous Malformation.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report a case of a 63-year-old man with severe pulmonary hemorrhage secondary to arteriovenous malformation and ventilatory failure due to reduced alveolar diffusion and airway obstruction. Bronchoscopy revealed high-flow active bleeding and clots obstructing the orotracheal tube and bronchial tree, refractory to local therapeutic measures. The patient was successfully supported with venovenous extracorporeal membrane oxygenation (ECMO) without systemic anticoagulation for 12 days as a bridge to definitive therapy. During this period, two angiographic arterial embolization attempts were unsuccessful, ultimately necessitating a right lower pulmonary lobectomy. In cases of massive hemoptysis, maintenance of airway patency and bleeding control should be carried out simultaneously. Treatment often includes bronchoscopy, angiographic arterial embolization, and, in the case of refractory bleeding, surgery. Venovenous ECMO provides short-term stabilization in pulmonary hemorrhage with refractory hypoxemic respiratory failure that is limiting a definitive intervention to achieve hemostasis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.